Literature DB >> 20530793

HS1 has a central role in the trafficking and homing of leukemic B cells.

Cristina Scielzo1, Maria T S Bertilaccio, Giorgia Simonetti, Antonis Dagklis, Elisa ten Hacken, Claudia Fazi, Marta Muzio, Valeria Caiolfa, Daisuke Kitamura, Umberto Restuccia, Angela Bachi, Martina Rocchi, Maurilio Ponzoni, Paolo Ghia, Federico Caligaris-Cappio.   

Abstract

The function of the intracellular protein hematopoietic cell-specific Lyn substrate-1 (HS1) in B lymphocytes is poorly defined. To investigate its role in migration, trafficking, and homing of leukemic B lymphocytes we have used B cells from HS1(-/-) mice, the HS1-silenced human chronic lymphocytic leukemia (CLL) MEC1 cell line and primary leukemic B cells from patients with CLL. We have used both in vitro and in vivo models and found that the lack of expression of HS1 causes several important functional effects. In vitro, we observed an impaired cytoskeletal remodeling that resulted in diminished cell migration, abnormal cell adhesion, and increased homotypic aggregation. In vivo, immunodeficient Rag2(-/-)γ(c)(-/-) mice injected with HS1-silenced CLL B cells showed a decreased organ infiltration with the notable exception of the bone marrow (BM). The leukemic-prone Eμ-TCL1 transgenic mice crossed with HS1-deficient mice were compared with Eμ-TCL1 mice and showed an earlier disease onset and a reduced survival. These findings show that HS1 is a central regulator of cytoskeleton remodeling that controls lymphocyte trafficking and homing and significantly influences the tissue invasion and infiltration in CLL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530793     DOI: 10.1182/blood-2009-12-258814

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.

Authors:  Michael Y Choi; George F Widhopf; Emanuela M Ghia; Reilly L Kidwell; Md Kamrul Hasan; Jian Yu; Laura Z Rassenti; Liguang Chen; Yun Chen; Emily Pittman; Minya Pu; Karen Messer; Charles E Prussak; Januario E Castro; Catriona Jamieson; Thomas J Kipps
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

2.  TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.

Authors:  Veronica Balatti; Lara Rizzotto; Cecelia Miller; Alexey Palamarchuk; Paolo Fadda; Rosantony Pandolfo; Laura Z Rassenti; Erin Hertlein; Amy S Ruppert; Arletta Lozanski; Gerard Lozanski; Thomas J Kipps; John C Byrd; Carlo M Croce; Yuri Pekarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.

Authors:  Aurore Perrot; Cédric Pionneau; Sophie Nadaud; Frédéric Davi; Véronique Leblond; Frédéric Jacob; Hélène Merle-Béral; Raoul Herbrecht; Marie-Christine Béné; John G Gribben; Seiamak Bahram; Laurent Vallat
Journal:  Blood       Date:  2011-05-20       Impact factor: 22.113

4.  RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.

Authors:  Anja Troeger; Amy J Johnson; Jenna Wood; William G Blum; Leslie A Andritsos; John C Byrd; David A Williams
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

5.  Adhesion structures in leukemia cells and their regulation by Src family kinases.

Authors:  Pavla Röselová; Adam Obr; Aleš Holoubek; Dana Grebeňová; Kateřina Kuželová
Journal:  Cell Adh Migr       Date:  2017-08-18       Impact factor: 3.405

6.  The actin regulatory protein HS1 is required for antigen uptake and presentation by dendritic cells.

Authors:  Yanping Huang; Chhanda Biswas; Deborah A Klos Dehring; Uma Sriram; Edward K Williamson; Shuixing Li; Fiona Clarke; Stefania Gallucci; Yair Argon; Janis K Burkhardt
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

7.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.

Authors:  Jerome Paggetti; Franziska Haderk; Martina Seiffert; Bassam Janji; Ute Distler; Wim Ammerlaan; Yeoun Jin Kim; Julien Adam; Peter Lichter; Eric Solary; Guy Berchem; Etienne Moussay
Journal:  Blood       Date:  2015-06-22       Impact factor: 22.113

8.  Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Authors:  Wenting Liu; Hiroaki Kajiyama; Kiyosumi Shibata; Yoshihiro Koya; Takeshi Senga; Fumitaka Kikkawa
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

9.  Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton.

Authors:  P B Knudsen; B Hanna; S Ohl; L Sellner; T Zenz; H Döhner; S Stilgenbauer; T O Larsen; P Lichter; M Seiffert
Journal:  Leukemia       Date:  2013-11-27       Impact factor: 11.528

10.  Cell Trafficking in Chronic Lymphocytic Leukemia.

Authors:  Matthew S Davids; Jan A Burger
Journal:  Open J Hematol       Date:  2012-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.